Despite dramatic expansion over the past 34 years, many rural and underserved hospitals continue to face significant ...
On July 31, 2025, the Health Resources and Services Administration (“HRSA”) announced the availability of a voluntary 340B Rebate Model Pilot Program (the “340B Rebate Pilot” or the “Pilot”) that ...
Ready or Not - HRSA’s 340B Rebate Pilot Model Takes Off Despite Questions on Readiness and Authority
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Michael J. Daugherty writes that lawmakers should help close loopholes in the 340B program used by some Michigan hospitals.
3don MSN
Minnesota nonprofit hospitals generating fortune off of government program spent millions overseas
Tax-exempt hospitals in Minnesota that have raked in large sums of revenue from a government safety net program spent tens of ...
The Trump administration's attempt to overhaul how safety net hospitals pay for outpatient drugs has run into a major legal wall, with a federal appeals court keeping a freeze on a controversial pilot ...
Providers are urging the government to abandon any plans to implement after-the-fact rebates in the 340B drug discount program, arguing it would impose undue costs on hospitals and clinics and ...
Michigan's 340B Drug Pricing Program, meant to help vulnerable patients, is being misused by hospitals, impacting care access ...
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law. Congress has been considering ...
This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of 340B drugs without the perverse incentives perpetuated by the current ...
Should preserving contract pharmacy arrangements be a policy priority when the evidence shows that many of these arrangements benefit large pharmacy chains and intermediaries as much—or more—than the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results